Hypersensitivity pneumonitis: Current concepts in pathogenesis, diagnosis, and treatment
Citations Over TimeTop 10% of 2021 papers
Abstract
Hypersensitivity pneumonitis is an immune-mediated interstitial lung disease caused by an aberrant response to an inhaled exposure, which results in mostly T cell-mediated inflammation, granuloma formation, and fibrosis in some cases. HP is diagnosed by exposure identification, HRCT findings of ground-glass opacities, centrilobular nodules, and mosaic attenuation, with traction bronchiectasis and honeycombing in fibrotic cases. Additional testing including serum IgG testing for the presence of antigen exposure, bronchoalveolar lavage lymphocytosis, and lung biopsy demonstrating granulomas, inflammation, and fibrosis, increases the diagnostic confidence. Treatment for HP includes avoidance of the implicated exposure, immunosuppression, and anti-fibrotic therapy in select cases. This narrative review presents the recent literature in the understanding of the immunopathological mechanisms, diagnosis, and treatment of HP.
Related Papers
- → Hypersensitivity pneumonitis: clinical, radiological and pathological profile of 103 patients from North India(2020)19 cited
- → Prognostic impact of bronchoalveolar lavage lymphocytosis in patients with chronic Hypersensitivity Pneumonitis(2018)5 cited
- → T-lymphocytosis in Bronchoalveolar Lavage Fluid of Hypersensitivity Pneumonitis(1985)7 cited
- → T-lymphocytosis in Bronchoalveolar Lavage Fluid of Hypersensitivity Pneumonitis(1985)2 cited
- → Fibrotic Hypersensitivity Pneumonitis Diagnosed by a Re-evaluation with Bronchoalveolar Lavage at Disease Deterioration(2022)